Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Endocrinology

Protecting Your Future: Lifelong Monitoring

At a Glance

To prevent serious complications from Type 2 diabetes, you need a lifelong monitoring schedule. This includes annual tests for kidney function (UACR and eGFR), daily foot checks, and regular dilated eye exams to catch and treat blood vessel damage early before it causes severe harm.

Living with Type 2 Diabetes (T2DM) is a marathon, not a sprint. Because high blood sugar can silently damage your body’s smallest and largest blood vessels over many years, lifelong monitoring is your most powerful tool for staying healthy and active [1][2].

The Two Types of Risks

Your monitoring plan is designed to protect you from two categories of complications:

  1. Microvascular (Small Vessel): These affect the tiny blood vessels in your eyes (retinopathy), kidneys (nephropathy), and nerves (neuropathy) [3].
  2. Macrovascular (Large Vessel): These affect the major arteries, increasing the risk of heart disease, stroke, and poor circulation in the legs [4][5].

Your Essential Screening Schedule

Because some damage can happen even before you are diagnosed, screenings should start immediately and continue regularly [6].

  • Eyes (Retinopathy): You should have your first dilated retinal exam at the time of your diagnosis [6]. If your results are normal, you should repeat this exam at least every 1 to 2 years. Note: The exam is painless; the doctor uses drops to widen your pupil and shines a light to look at the back of your eye.
  • Kidneys (Nephropathy): Your doctor will check your urine for protein (UACR) and your blood for filtration speed (eGFR) at diagnosis and at least once every year thereafter [7][8].
  • Nerves and Feet (Neuropathy): You should have a comprehensive foot exam once a year. This is a simple, painless test where the doctor checks your reflexes and uses a soft piece of plastic (monofilament) to test sensation on the bottom of your foot [3]. However, you should inspect your own feet every day for any small injuries you might not be able to feel.
  • Heart and Arteries: Blood pressure and weight are checked at every visit, and your cholesterol (specifically non-HDL cholesterol) should be checked at least annually to predict your heart disease risk [9][10].

Managing the “Diabetes Distress”

The constant need for testing, monitoring, and medication can lead to diabetes distress—a feeling of being overwhelmed or burnt out by the demands of the disease [11]. This affects more than one-third of people living with diabetes and can make it harder to keep up with self-care [12][13].

If you find yourself feeling exhausted or hopeless about your monitoring routine, know that this is a recognized medical challenge. Psychological support, peer groups, and even new technologies like automated monitors can help reduce this emotional burden and improve your quality of life [14][15].

The Predictors of Success

The best way to slow the progression of these complications is to manage the “Big Three” [1][7]:

  1. HbA1c: Keeping your average blood sugar in your target range.
  2. Blood Pressure: High blood pressure is a major driver of kidney and heart damage.
  3. Lipids: Managing cholesterol to protect your heart.

By catching changes early through regular screenings, you and your doctor can adjust your treatment—such as adding organ-protective medications—before minor issues become major health problems [16][17].

Common questions in this guide

How often do I need an eye exam for type 2 diabetes?
You should have a dilated retinal exam right when you are diagnosed with type 2 diabetes. If the results are normal, the exam should be repeated at least every one to two years to check for early signs of eye damage.
What kidney tests do I need if I have type 2 diabetes?
Your doctor will check your urine for protein (UACR) and test your blood to measure your kidney filtration speed (eGFR). These should be done at your initial diagnosis and at least once a year after that.
What is diabetes distress and is it normal?
Diabetes distress is a feeling of burnout or being overwhelmed by the constant demands of testing and managing the disease. It is a common medical challenge that can be managed with psychological support, peer groups, or new monitoring technologies.
How do I monitor my feet for diabetic nerve damage?
You should have a comprehensive foot exam by your doctor once a year to check reflexes and sensation. At home, you must inspect the bottoms of your feet every day for cuts, blisters, or redness that you might not be able to feel due to nerve damage.
What is the best way to prevent diabetes complications?
You can slow the progression of complications by managing the "Big Three": keeping your HbA1c in your target range, controlling your blood pressure, and managing your cholesterol levels.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.When and where should I schedule my first dilated retinal eye exam?
  2. 2.What was my most recent UACR (urine protein) result, and how does it compare to my baseline?
  3. 3.Does my current blood pressure put me at a higher risk for diabetic kidney disease?
  4. 4.How often should we perform a comprehensive foot exam to check for nerve damage (neuropathy)?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    The concordance and discordance of diabetic kidney disease and retinopathy in patients with type 2 diabetes mellitus: A cross-sectional study of 26,809 patients from 5 primary hospitals in China.

    Liu Z, Li X, Wang Y, et al.

    Frontiers in endocrinology 2023; (14()):1133290 doi:10.3389/fendo.2023.1133290.

    PMID: 36967757
  2. 2

    AGEs accumulation with vascular complications, glycemic control and metabolic syndrome: A narrative review.

    Pal R, Bhadada SK

    Bone 2023; (176()):116884 doi:10.1016/j.bone.2023.116884.

    PMID: 37598920
  3. 3

    Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: a prospective cohort study in Sweden.

    Asplund O, Thangam M, Prasad RB, et al.

    The lancet. Diabetes & endocrinology 2026; (14(1)):29-40 doi:10.1016/S2213-8587(25)00283-9.

    PMID: 41248671
  4. 4

    Stratifying atherosclerotic cardiovascular disease by SMuRF burden in a Middle-Eastern country: A multiregistry study of demographics, comorbidities, and therapeutic trends.

    Alkouri O, Albikawi Z, Saifan AR, et al.

    PloS one 2025; (20(9)):e0332302 doi:10.1371/journal.pone.0332302.

    PMID: 40982559
  5. 5

    Pan-immune-inflammation value predicts proliferative diabetic retinopathy in patients with diabetes mellitus and atherosclerotic cardiovascular disease.

    Kurtul A, Kurtul BE, Elbeyli A

    Revista da Associacao Medica Brasileira (1992) 2025; (71(8)):e20250489 doi:10.1590/1806-9282.20250489.

    PMID: 40990753
  6. 6

    Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.

    Zaharia OP, Strassburger K, Strom A, et al.

    The lancet. Diabetes & endocrinology 2019; (7(9)):684-694 doi:10.1016/S2213-8587(19)30187-1.

    PMID: 31345776
  7. 7

    Risk factors for developing hypertension in patients with type 2 diabetes: A cross-sectional study.

    Liu L, Mu J, Wang X, et al.

    Medicine 2025; (104(26)):e43104 doi:10.1097/MD.0000000000043104.

    PMID: 40587674
  8. 8

    Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry.

    Yeh YK, Lin KH, Sheu WH, et al.

    BMC nephrology 2024; (25(1)):133 doi:10.1186/s12882-024-03567-1.

    PMID: 38622535
  9. 9

    Non-high-density lipoprotein cholesterol predicts cardiovascular risk better than remnant cholesterol in patients with type 2 diabetes mellitus.

    Nsiah P, Acquah S, Bockarie AS, et al.

    Frontiers in cardiovascular medicine 2025; (12()):1551203 doi:10.3389/fcvm.2025.1551203.

    PMID: 40662131
  10. 10

    Assessing mortality risk in Type 2 Diabetes patients with prolonged ASCVD risk factors: the inclusive Poh-Ai predictive scoring system with CAC Score integration.

    Lei MH, Hsu YC, Chung SL, et al.

    Diabetology & metabolic syndrome 2024; (16(1)):104 doi:10.1186/s13098-024-01341-9.

    PMID: 38764060
  11. 11

    Prevalence of diabetes distress and cross-cultural reliability of DDS-17 scale in rural Haryana.

    Ranjan R, Rajput M, Sachdeva A, et al.

    Journal of family medicine and primary care 2023; (12(9)):2064-2069 doi:10.4103/jfmpc.jfmpc_496_23.

    PMID: 38024882
  12. 12

    Diabetes Distress and Associations With Demographic and Clinical Variables: A Nationwide Population-Based Registry Study of 10,186 Adults With Type 1 Diabetes in Norway.

    Hernar I, Cooper JG, Nilsen RM, et al.

    Diabetes care 2024; (47(1)):126-131 doi:10.2337/dc23-1001.

    PMID: 37922320
  13. 13

    Psychological resilience mediates the relationship between diabetes distress and depression among persons with diabetes in a multi-group analysis.

    Wojujutari AK, Idemudia ES, Ugwu LE

    Scientific reports 2024; (14(1)):6510 doi:10.1038/s41598-024-57212-w.

    PMID: 38499620
  14. 14

    Patient reported outcome measures in children and adolescents with type 1 diabetes using advanced hybrid closed loop insulin delivery.

    Gianini A, Suklan J, Skela-Savič B, et al.

    Frontiers in endocrinology 2022; (13()):967725 doi:10.3389/fendo.2022.967725.

    PMID: 36060958
  15. 15

    Putting person-centred psychosocial diabetes care into practice: two psychosocial care pathways based on outcome preferences of people with diabetes and healthcare professionals.

    Porth AK, Seidler Y, Long PA, et al.

    BMJ mental health 2024; (27(1)) doi:10.1136/bmjment-2024-301061.

    PMID: 39182922
  16. 16

    Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta-Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials.

    Giugliano D, Maiorino MI, Bellastella G, et al.

    Journal of the American Heart Association 2019; (8(12)):e012356 doi:10.1161/JAHA.119.012356.

    PMID: 31166153
  17. 17

    Diabetes Mellitus and Heart Failure.

    Lehrke M, Marx N

    The American journal of cardiology 2017; (120(1S)):S37-S47 doi:10.1016/j.amjcard.2017.05.014.

    PMID: 28606342

This page provides general screening guidelines for Type 2 Diabetes for educational purposes only. Always consult your healthcare team for a personalized monitoring and treatment plan.

Get notified when new evidence is published on type 2 diabetes mellitus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.